Similarly, EZH2 is an important regulator of normal and malignant hematopoiesis50, while HNRNPDL overexpression in CML cells has been shown to induce leukemia in vivo34. This evidence concerns the gene EZH2 and chronic myelogenous leukemia, BCR-ABL1 positive.